Mexico for Biotech / Life Sciences

Mexico ranks #16 of 25 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 54/100. The top strengths for Biotech / Life Sciences founders are funding access and family viability. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

Mexico applies a statutory corporate tax rate of 30%. The jurisdiction has 65 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

COFEPRIS regulates drugs and devices with moderate timelines, often accepting reference to FDA decisions. Mexico has a significant clinical trial infrastructure and lower costs than the US. Diverse patient populations useful for Phase II/III trials. Mexico offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

Mexico ranks #16 for Biotech / Life Sciences with 54/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by corporate tax, where Mexico is weaker. Use NomadSignal's comparison pages to evaluate Mexico head-to-head against specific alternatives.